Table 1.
Extraction of PHC Elements for Patients With diabetes.
| No | Method | Population | PG/LS | BB/EB | GT | PP | GC | ICP | SM | PRDC | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Abbate, Mannucci, Cioni, Fatini, and Marcucci (2012) [14] | LR | Type 1 and type 2 diabetes | × | |||||||
| 2. | Meneghini & Reid (2012) [15] | LR | Type 2 diabetes | × | × | × | |||||
| 3. | Spiegel and Hawkins (2012) [16] | LR | Type 2 diabetes | × | × | ||||||
| 4. | Paschou and Leslie (2013) [17] | LR | Type 2 diabetes | × | × | × | |||||
| 5. | Subramanian and Hirsch (2014) [18] | LR | Type 2 diabetes | × | × | × | |||||
| 6. | Davies et al. (2015) [19] | RCT | Type 2 diabetes | × | |||||||
| 7. | Groop, (2015) [20] | LR | Type 1 and type 2 diabetes | × | |||||||
| 8. | Jameson and Longo (2015) [8] | LR | Type 1 and type 2 diabetes | × | × | ||||||
| 9. | Sexton (2016) [21] | LR | Interdisciplinary teamwork care | × | |||||||
| 10. | Sherifali et al. (2016) [4] | LR | Type 2 diabetes | × | |||||||
| 11. | Sherifali (2016) [22] | LR | Type 2 diabetes | × | × | ||||||
| 12. | Krag et al. (2016) [23] | RCT | Type 2 diabetes | × | |||||||
| 13. | Miñambres, Mediavilla, Sarroca, and Pérez (2016) [24] | CSA | Type 2 diabetes | × | × | ||||||
| 14. | Pearson (2016) [25] | LR | Type 2 diabetes | × | × | ||||||
| 15. | Fradkin, Hanlon, and Rodgers (2016) [26] | LR | Type 1 and type 2 diabetes | × | × | ||||||
| 16. | Holt (2016) [27] | LR | Type 2 diabetes | × | × | × | |||||
| 17. | Florez (2016) [28] | LR | Type 1 and type 2 diabetes | × | |||||||
| 18. | Meyer (2016) [29] | LR | Type 2 diabetes | × | |||||||
| 19. | Arnett and Claas (2016) [30] | LR | Type 1 and type 2 diabetes | × | |||||||
| 20. | Scheen (2016) [31] | LR | Type 2 diabetes | × | |||||||
| 21. | Floyd and Psaty (2016) [32] | LR | Type 2 diabetes | × | |||||||
| 22. | Rich and Cefalu (2016) [33] | LR | Type 2 diabetes | × | × | ||||||
| 23. | Krinsley, Preiser, and Hirsch (2017) [34] | CHT | Type 2 diabetes | × | × | ||||||
| 24. | Sherifali (2017) [5] | LR | Type 2 diabetes | × | |||||||
| 25. | Mahato, Srivastava, and Chandra (2017) [35] | LR | Type 1 and type 2 diabetes | × | |||||||
| 26. | Mayor (2017) [36] | LR | Type 2 diabetes | × | × | × | × | × | |||
| 27. | Mutie, Giordano, and Franks (2017) [37] | LR | Type 2 diabetes | × | × | ||||||
| 28. | Fitipaldi, McCarthy, Florez, and Franks (2018) [38] | LR | Type 2 diabetes | × | × | ||||||
| 29. | Horwitz, Charlson, and Singer (2018) [39] | LR | Type 2 diabetes | × | |||||||
| 30. | Greener (2018) [40] | LR | Type 1 and type 2 diabetes | × | × | ||||||
| 31. | Burke, Trinidad, and Schenck (2019) [41] | LR | Type 2 diabetes | × | |||||||
| 32. | Mannino, Andreozzi, and Sesti (2019) [42] | LR | Type 2 diabetes | × | |||||||
| 33. | Mohan and Radha (2019) [43] | LR | Type 1 and type 2 diabetes | × | × | ||||||
| 34. | Leggio, Tiberti, Armeni, Limongelli, and Mazza (2019) [44] | LR | Type 2 diabetes | × | × | ||||||
| 35. | Prasad and Groop (2019) [45] | LR | Type 2 diabetes | × | × |
Note: LR: literature review; CSA: cross-sectional analysis; RCT: randomized controlled trial; CHT: cohort study; PG/LS: personalized genetic or lifestyle; BB/EB: biodata- or evidence-based; GT: glycemic target; PP: patient preferences; GC: glycemic control; ICP: interdisciplinary collaboration practice; SM: self-management; PRDC: Patient priority direct care.